Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik Ossenkoppele

Showing results (261-270 of 295) with videos related to

Pageof 30
Sort By:
Alzheimer'S Research & Therapy|May 25, 2019
Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease: protocol of the BEAT-IT studyWillem S Eikelboom, Ellen Singleton, Esther van den Berg, et al.
Annals of Neurology|June 18, 2024
Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter StudyDavid N Soleimani-Meigooni, Ruben Smith, Karine Provost, et al.
Neuroimage|July 22, 2025
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's diseaseVikram Venkatraghavan, Damiano Archetti, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|July 5, 2015
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological featuresRik Ossenkoppele, Yolande A L Pijnenburg, David C Perry, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 20, 2020
The impact of demographic, clinical, genetic, and imaging variables on tau PET statusRik Ossenkoppele, Antoine Leuzy, Hanna Cho, et al.
JAMA Neurology|June 28, 2021
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance ImagingRik Ossenkoppele, Ruben Smith, Niklas Mattsson-Carlgren, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 2021
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's diseaseEllen Singleton, Oskar Hansson, Yolande A L Pijnenburg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
The Lancet. Neurology|October 25, 2020
Amyloid-PET and <sup>18</sup>F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Javier Arbizu, Henryk Barthel, et al.
Pageof 30

Showing results (261-270 of 295) with videos related to

Sort By:
Pageof 30
Alzheimer'S Research & Therapy|May 25, 2019
Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease: protocol of the BEAT-IT studyWillem S Eikelboom, Ellen Singleton, Esther van den Berg, et al.
Annals of Neurology|June 18, 2024
Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter StudyDavid N Soleimani-Meigooni, Ruben Smith, Karine Provost, et al.
Neuroimage|July 22, 2025
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's diseaseVikram Venkatraghavan, Damiano Archetti, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|July 5, 2015
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological featuresRik Ossenkoppele, Yolande A L Pijnenburg, David C Perry, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 20, 2020
The impact of demographic, clinical, genetic, and imaging variables on tau PET statusRik Ossenkoppele, Antoine Leuzy, Hanna Cho, et al.
JAMA Neurology|June 28, 2021
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance ImagingRik Ossenkoppele, Ruben Smith, Niklas Mattsson-Carlgren, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 2021
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's diseaseEllen Singleton, Oskar Hansson, Yolande A L Pijnenburg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
The Lancet. Neurology|October 25, 2020
Amyloid-PET and <sup>18</sup>F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Javier Arbizu, Henryk Barthel, et al.
Pageof 30